We conduct phase I through phase III multi-institutional trials. The design and analysis of a wide variety of oncology clinical trials constitutes the majority of our work. Trials range from Phase I single or multi-institution industry sponsored to Phase III multi-institutional trials.
MORE ABOUT BIOSTATISTIC SERVICES
Data collection, management and quality are our top priority. At CRAB, we believe the collection, monitoring and management of data are crucial to quality research and science.
Cancer Research And Biostatistics (CRAB) CEO, Antje Hoering, PhD, is in La Jolla, California, this week where she serves as faculty for the American Society of Hematology Clinical Research Training Institute (ASH CRTI). ASH CRTI is a unique training program for early career hematologists. It comprises a week-long workshop aimed at equipping hematologists with foundational […]
Friends of Cancer Research work on ctDNA focuses on collaboratively establishing evidence to support the use of ctDNA as an early endpoint. Cancer Research And Biostatistics (CRAB) serves as the independent analysis center for this project and as such we are responsible for all the analyses. CRAB is incredibly proud to be part of this […]
Cancer Research And Biostatistics (CRAB) founder John Crowley, PhD and CRAB CEO, Antje Hoering, PhD, were invited by Taylor & Francis Group to serve as editors for the Fourth Edition of the Handbook of Statistics in Clinical Oncology. For this fourth edition, Megan Othus, PhD, from the Fred Hutch will join the editorial team. Many […]
Partner with CRAB
CRAB's expertise in biostatistics, data management, application development and DMC statistical and meeting management provides reliable and defensible results for your clinical trial.
CRAB has supported more than 300 adult clinical trials. Many of the trials conducted through CRAB have been in large-scale Phase III trials. We have expertise across all trial phases including multi-institutional Phase I trials. The other studies (15%) are comprised of biological correlative studies, registries, post-marketing trials and outcomes research. CRAB statisticians have decades of experience in the design and analysis of a wide variety of oncology clinical trials.
CRAB achieves its mission through long-standing partnerships with both research collaborators and with for-profit organizations. The SWOG Statistics and Data Management Center (SDMC) is co-located at Fred Hutch and CRAB. SWOG is one of five U.S.-based National Cancer Institute-supported cooperative groups within the National Clinical Trials Network (NCTN). CRAB’s Clinical Research Services (CRS) division has a number of key partnerships with research consortia as well as pharmaceutical clients. Other important collaborations for CRAB are with Friends of Cancer Research (Friends) and the International Association For The Study Of Lung Cancer (IASLC).